본문으로 건너뛰기
← 뒤로

Steroid-Resistant Relapse of Autoimmune Pancreatitis with Marked Main Pancreatic Duct Dilatation Mimicking Multifocal Pancreatic Cancer.

1/5 보강
Internal medicine (Tokyo, Japan) 2026
Retraction 확인
출처

Hirano K, Kondo K, Saito T, Takahashi K, Ono S, Abe S, Kato T, Kobayashi K, Sekigawa K, Mitsui H

📝 환자 설명용 한 줄

A 67-year-old man with type 1 autoimmune pancreatitis (AIP) and IgG4-related sclerosing cholangitis experienced a relapse, while presenting with pancreatic head swelling and distal bile duct stenosis.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Hirano K, Kondo K, et al. (2026). Steroid-Resistant Relapse of Autoimmune Pancreatitis with Marked Main Pancreatic Duct Dilatation Mimicking Multifocal Pancreatic Cancer.. Internal medicine (Tokyo, Japan). https://doi.org/10.2169/internalmedicine.6704-25
MLA Hirano K, et al.. "Steroid-Resistant Relapse of Autoimmune Pancreatitis with Marked Main Pancreatic Duct Dilatation Mimicking Multifocal Pancreatic Cancer.." Internal medicine (Tokyo, Japan), 2026.
PMID 41535040

Abstract

A 67-year-old man with type 1 autoimmune pancreatitis (AIP) and IgG4-related sclerosing cholangitis experienced a relapse, while presenting with pancreatic head swelling and distal bile duct stenosis. Despite an increase in the prednisolone dosage (from 7.5 20 mg/day), the disease worsened. A significant dilatation of the main pancreatic duct (8 mm) and new stenosis of the pancreatic tail duct were observed. Malignancy was ruled out by repeated endoscopic ultrasound-guided fine-needle aspiration biopsies. A further escalation of the prednisolone dose to 40 mg/day led to clinical and radiological improvements. This case underscores the difficulty in distinguishing a steroid-resistant AIP relapse from pancreatic cancer, and the importance of ruling out malignancy before intensifying immunosuppressive therapy.

같은 제1저자의 인용 많은 논문 (1)